Newell, P. Et Al. 2009. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. JOURNAL OF HEPATOLOGY , vol.51, no.4 , 725-733.

Newell, P., Toffanin, S., Villanueva, A., Chiang, D. Y., Minguez, B., Cabellos, L., ... Savic, R.(2009). Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. JOURNAL OF HEPATOLOGY , vol.51, no.4, 725-733.

Newell, Pippa Et Al. "Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo," JOURNAL OF HEPATOLOGY , vol.51, no.4, 725-733, 2009

Newell, Pippa Et Al. "Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo." JOURNAL OF HEPATOLOGY , vol.51, no.4, pp.725-733, 2009

Newell, P. Et Al. (2009) . "Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo." JOURNAL OF HEPATOLOGY , vol.51, no.4, pp.725-733.

@article{article, author={Pippa Newell Et Al. }, title={Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo}, journal={JOURNAL OF HEPATOLOGY}, year=2009, pages={725-733} }